{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:28:32Z","timestamp":1785374912306,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH075673"],"award-info":[{"award-number":["MH075673"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s13365-017-0587-z","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:34:47Z","timestamp":1508805287000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-8058","authenticated-orcid":false,"given":"Ned","family":"Sacktor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Skolasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Haughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"587_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0028-3932(67)90015-2","volume":"5","author":"J Borkowski","year":"1967","unstructured":"Borkowski J, Benton A, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5:135\u2013140","journal-title":"Neuropsychologia"},{"key":"587_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/13854049108403297","volume":"5","author":"J Brandt","year":"1991","unstructured":"Brandt J (1991) The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 5:125\u2013142","journal-title":"Clin Neuropsychol"},{"key":"587_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307\u2013319","journal-title":"J Clin Exp Neuropsychol"},{"key":"587_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)35063-3","volume":"291","author":"J Choi","year":"1999","unstructured":"Choi J, Hahn S, Rhie D, Yoon S, Jo Y, Kim M (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1\u20136","journal-title":"J Pharmacol Exp Ther"},{"key":"587_CR5","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1097\/00001756-200312190-00032","volume":"14","author":"B Choi","year":"2003","unstructured":"Choi B, Choi J, Ahn H, Kim MJ, Rhie D, Yoon S, Min D, Jo Y, Kim MS, Hahn S (2003) Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4. Neuroreport 14:2451\u20132455","journal-title":"Neuroreport"},{"key":"587_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/01.WNL.0000034177.47015.DA","volume":"59","author":"DB Clifford","year":"2002","unstructured":"Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM (2002) A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology 59:1568\u20131573","journal-title":"Neurology"},{"key":"587_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/00221325.1962.10533572","volume":"100","author":"PE Comalli Jr","year":"1962","unstructured":"Comalli PE Jr, Wapner S, Werner H (1962) Interference effects of Stroop color-word test in childhood, adulthood, and aging. J Genet Psychol 100:47\u201353","journal-title":"J Genet Psychol"},{"key":"587_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ana.410330502","volume":"33","author":"LG Epstein","year":"1993","unstructured":"Epstein LG, Gendelman HE (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33:429\u2013436","journal-title":"Ann Neurol"},{"key":"587_CR9","first-page":"1520","volume":"11","author":"S Galgani","year":"1997","unstructured":"Galgani S, Balestra P, Narciso P, Tozzi V, Sette P, Pau F, Visco G (1997) Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits. AIDS (London, England) 11:1520\u20131521","journal-title":"AIDS (London, England)"},{"key":"587_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13365-011-0023-8","volume":"17","author":"NS Gandhi","year":"2011","unstructured":"Gandhi NS, Skolasky RL, Peters KB, Moxley RTT, Creighton J, Roosa HV, Selnes OA, McArthur J, Sacktor N (2011) A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J Neurovirol 17:159\u2013165","journal-title":"J Neurovirol"},{"key":"587_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.10828","volume":"55","author":"NJ Haughey","year":"2004","unstructured":"Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol 55:257\u2013267","journal-title":"Ann Neurol"},{"key":"587_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archneur.55.1.41","volume":"55","author":"PN Heseltine","year":"1998","unstructured":"Heseltine PN, Goodkin K, Atkinson JH, Vitiello B, Rochon J, Heaton RK, Eaton EM, Wilkie FL, Sobel E, Brown SJ, Feaster D, Schneider L, Goldschmidts WL, Stover ES (1998) Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol 55:41\u201351","journal-title":"Arch Neurol"},{"key":"587_CR13","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0025-7125(16)33515-5","volume":"47","author":"H Klove","year":"1963","unstructured":"Klove H (1963) Clinical neuropsychology. Med Clin N Am 47:1647\u20131658","journal-title":"Med Clin N Am"},{"key":"587_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","volume":"69","author":"Y Lampl","year":"2007","unstructured":"Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69:1404\u20131410","journal-title":"Neurology"},{"key":"587_CR15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","volume":"67","author":"JC McArthur","year":"2010","unstructured":"McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67:699\u2013714","journal-title":"Ann Neurol"},{"key":"587_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13365-014-0283-1","volume":"20","author":"KA Meulendyke","year":"2014","unstructured":"Meulendyke KA, Queen SE, Engle EL, Shirk EN, Liu J, Steiner JP, Nath A, Tarwater PM, Graham DR, Mankowski JL, Zink MC (2014) Combination fluconazole\/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. J Neurovirol 20:591\u2013602","journal-title":"J Neurovirol"},{"key":"587_CR17","volume-title":"California Computerized Assessment Package, (CALCAP)","author":"EN Miller","year":"1990","unstructured":"Miller EN (1990) California Computerized Assessment Package, (CALCAP). CALCAP, Los Angeles"},{"key":"587_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.51.1.221","volume":"51","author":"BA Navia","year":"1998","unstructured":"Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA (1998) A phase I\/II trial of nimodipine for HIV-related neurologic complications. Neurology 51:221\u2013228","journal-title":"Neurology"},{"key":"587_CR19","first-page":"206","volume":"30","author":"PA Osterrieth","year":"1944","unstructured":"Osterrieth PA (1944) Le test de copie d\u2019une figure complexe: contribution a l\u2019etude de la perception et de la memoire. Arch Psychol 30:206\u2013356","journal-title":"Arch Psychol"},{"key":"587_CR20","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-3565(24)29480-5","volume":"298","author":"L Perchenet","year":"2001","unstructured":"Perchenet L, Hilfiger L, Mizrahi J, Clement-Chomienne O (2001) Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5. J Pharmacol Exp Ther 298:1108\u20131119","journal-title":"J Pharmacol Exp Ther"},{"key":"587_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385\u2013401","journal-title":"Appl Psychol Meas"},{"key":"587_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"R Reitan","year":"1958","unstructured":"Reitan R (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8:271\u2013276","journal-title":"Percept Mot Skills"},{"key":"587_CR23","volume-title":"Neuropsychology laboratory","author":"R Reitan","year":"1979","unstructured":"Reitan R (1979) Manual for administration of neuropsychological test batteries for adults and children. In: Laboratory N (ed) Neuropsychology laboratory. Neuropsychology Laboratory, Tucson"},{"key":"587_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s13365-013-0195-5","volume":"19","author":"LS Rosenthal","year":"2013","unstructured":"Rosenthal LS, Skolasky RL, Moxley RT, Roosa HV, Selnes OA, Eschman A, McArthur JC, Sacktor N (2013) A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder. J Neurovirol 19:432\u2013441","journal-title":"J Neurovirol"},{"key":"587_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.49.1.142","volume":"49","author":"NC Sacktor","year":"1997","unstructured":"Sacktor NC (1997) The Dana Consortium on the therapy for HIV Dementia and related cognitive disorders. Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. Neurology 49:142\u2013146","journal-title":"Neurology"},{"key":"587_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.50.3.645","volume":"50","author":"N Sacktor","year":"1998","unstructured":"Sacktor N (1998) The Dana Consortium on the therapy for HIV Dementia and related cognitive disorders: a randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in HIV-associated cognitive impairment. Neurology 50:645\u2013651","journal-title":"Neurology"},{"key":"587_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1212\/WNL.54.1.233","volume":"54","author":"N Sacktor","year":"2000","unstructured":"Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K (2000) Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology 54:233\u2013235","journal-title":"Neurology"},{"key":"587_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1212\/WNL.0b013e31822f0412","volume":"77","author":"N Sacktor","year":"2011","unstructured":"Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, Paul R, Robertson K, Jarocki B, Scarsi K, Coombs RW, Zink MC, Nath A, Smith E, Ellis RJ, Singer E, Weihe J, McCarthy S, Hosey L, Clifford DB (2011) Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology 77:1135\u20131142","journal-title":"Neurology"},{"key":"587_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment. Nat Rev Neurol 12:309","journal-title":"Nat Rev Neurol"},{"key":"587_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1212\/WNL.53.2.391","volume":"53","author":"G Schifitto","year":"1999","unstructured":"Schifitto G, Sacktor N, Marder K, McDermott M, McArthur J, Kieburtz K, Small S, Epstein LG (1999) Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology 53:391\u2013396","journal-title":"Neurology"},{"key":"587_CR31","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","volume":"21","author":"G Schifitto","year":"2007","unstructured":"Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA (2007a) Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS (London, England) 21:1877\u20131886","journal-title":"AIDS (London, England)"},{"key":"587_CR32","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","volume":"69","author":"G Schifitto","year":"2007","unstructured":"Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB (2007b) A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 69:1314\u20131321","journal-title":"Neurology"},{"key":"587_CR33","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1212\/WNL.0b013e3181c51a48","volume":"73","author":"G Schifitto","year":"2009","unstructured":"Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB (2009) Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology 73:1975\u20131981","journal-title":"Neurology"},{"key":"587_CR34","unstructured":"Smith A (1968) The symbol digit modalities test: a neuropsychologic test of learning and other cerebral disorders. Special Child Publications, Seattle, Washington"},{"key":"587_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s13311-014-0315-9","volume":"12","author":"JP Steiner","year":"2015","unstructured":"Steiner JP, Bachani M, Wolfson-Stofko B, Lee MH, Wang T, Li G, Li W, Strayer D, Haughey NJ, Nath A (2015) Interaction of paroxetine with mitochondrial proteins mediates neuroprotection. Neurotherapeutics 12:200\u2013216","journal-title":"Neurotherapeutics"},{"key":"587_CR36","unstructured":"Uthman OA, Abdulmalik JO (2008) Adjunctive therapies for AIDS dementia complex. The Cochrane database of systematic reviews, Cd006496"},{"key":"587_CR37","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/sj.bjp.0702955","volume":"128","author":"SY Yeung","year":"1999","unstructured":"Yeung SY, Millar JA, Mathie A (1999) Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol 128:1609\u20131615","journal-title":"Br J Pharmacol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-017-0587-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:03:18Z","timestamp":1750960998000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-017-0587-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1007\/s13365-017-0587-z","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"assertion":[{"value":"12 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs Sacktor, Skolasky, Wang, Mielke, Munro, Haughey, McArthur, and Mr. Moxley report no financial relationship with NIH which sponsored the research. Drs Steiner and Nath are employed by NIH. All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, CFAR, NCATS or NIH.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}